Aptamer extends contract with Unilever to progress Optimer for deodorant development

Lab-test results of Optimer indicate good applicability in deodorant products.

Pharmalittle: We’re reading about cracks in the MAHA alliance, pharmacies suing GoodRx and PBMs, and more

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal

December 6, 2024

Non-Erosive GERD May Not Increase Risk of Esophageal Cancer

Patients with non-erosive gastroesophageal reflux disease (GERD) appear to have a similar incidence of esophageal adenocarcinoma as the general population, according to a large Nordic

September 19, 2023

Following lower-than-expected profits, Evotec plans to cut costs, completes CEO search

Evotec announced a “reset” to its business plan as it reported financial results Wednesday, following a year in which many contract drug manufacturers have struggled.

April 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.